Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-100758
Filing Date
2024-04-18
Accepted
2024-04-18 16:03:51
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d812108ddefa14a.htm DEFA14A 22359
2 GRAPHIC g812108g11y01.jpg GRAPHIC 7935
3 GRAPHIC g812108g11y02.jpg GRAPHIC 22188
4 GRAPHIC g812108g11y03.jpg GRAPHIC 61812
5 GRAPHIC g812108g11y04.jpg GRAPHIC 3508
6 GRAPHIC g812108g11y05.jpg GRAPHIC 3028
7 GRAPHIC g812108g11y06.jpg GRAPHIC 2940
8 GRAPHIC g812108g11z41.jpg GRAPHIC 4775
9 GRAPHIC g812108g20r57.jpg GRAPHIC 4125
  Complete submission text file 0001193125-24-100758.txt   176407
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40800 | Film No.: 24854298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)